Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis. [electronic resource]
Producer: 20190801Description: 1923-1932 p. digitalISSN:- 2326-5205
- Adalimumab -- pharmacology
- Adult
- Antirheumatic Agents -- pharmacology
- Arthritis, Rheumatoid -- blood
- Azetidines -- pharmacology
- Clinical Trials, Phase III as Topic
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Lymphocyte Count
- Lymphocyte Subsets -- drug effects
- Male
- Middle Aged
- Purines
- Pyrazoles
- Randomized Controlled Trials as Topic
- Sulfonamides -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.